AYTU BIOPHARMA, INC Assets, Noncurrent
AYTU BIOPHARMA, INC (AYTU) had Assets, Noncurrent of $43.25 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-09-22
- 2026-06-30: Assets, Noncurrent $43.25M.
- 2026-03-31: Assets, Noncurrent $44.36M.
- 2025-12-31: Assets, Noncurrent $45.76M.
- 2025-09-30: Assets, Noncurrent $43.88M.
| Period end | Assets, Noncurrent | Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $43.25M 10-K · filed 2026-09-22 | |
| 2026-03-31 | $44.36M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $45.76M 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $43.88M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $45.00M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $51.69M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $53.17M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $55.09M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $56.20M 10-K · filed 2025-09-23 | |
| 2024-03-31 | $57.73M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $59.88M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $62.29M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $65.38M 10-K · filed 2024-09-26 | $63.63M 10-K · filed 2023-10-12 |
| 2023-03-31 | $68.75M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $70.83M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $75.58M 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | $77.69M 10-K · filed 2023-10-12 | |
| 2022-03-31 | $90.88M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $136.28M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $138.69M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $160.43M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $171.54M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $74.20M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $75.82M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $77.87M 10-K · filed 2021-09-28 | $77.87M 10-K · filed 2020-10-06 |
| 2020-03-31 | $75.70M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $56.14M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $19.04M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $19.29M 10-K · filed 2020-10-06 | |
| 2019-03-31 | $19.88M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $20.42M 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $11.11M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $11.59M 10-K · filed 2019-09-26 | |
| 2018-03-31 | $8.78M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $11.11M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $11.50M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $11.97M 10-K · filed 2018-09-06 | |
| 2017-03-31 | $11.48M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $13.35M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $13.84M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $14.22M 10-K · filed 2017-08-31 | |
| 2016-03-31 | $11.55M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $11.65M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $10.05M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $10.14M 10-K · filed 2016-09-01 | |
| 2015-03-31 | $8.55M 10-Q · filed 2015-05-19 | |
| 2014-06-30 | $8.71M 10-K · filed 2015-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |